A recent proteomic study reported elevated plasma C4A levels in schizophrenia cases, linking with the genetics and implying that measurement of the C4A isotype may provide a more suitable biomarker than measurement of total C4 [218]. The gene discussed is C4A; the disease is schizophrenia.